TrialJournal for immunotherapy of cancer2023

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.

Mehmet Akce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.